Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 112 participants.
Also called NCT05666128
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 112 participants
- Sponsor
- Registry
-
NCT05666128
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT05666128. Randomized; double masking; primary purpose treatment. Start 2022-06-17 (actual); primary completion 2023-06-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- HD-6277
- Intervention (Drug)
- HD-6277
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hyundai Pharm
Record details
- Record id
cardio:ct-nct05666128- Content hash
8e53293d9477fe4ab6c7a33554226290d638e869cfc79a515ac9bfd3a45cd659